ResMed Inc (ASX:RMD) Global General Counsel and Secretary Michael J. Rider disposed of 400 shares of ResMed common stock on 23 October 2026 at a price of $255 per share, according to a statement of changes in beneficial ownership filed with the United States Securities and Exchange Commission.

Key Points

  • Michael J. Rider, Global General Counsel and Secretary of ResMed, sold 400 shares of ResMed common stock on 23 October 2026
  • The shares were sold at $255 each, with the transaction conducted under a Rule 10b5-1 plan adopted on 28 February 2025
  • Following the transaction, Rider holds 12,318 shares of ResMed common stock directly
  • The filing was signed and submitted on 26 October 2026

Transaction Details for 23 October 2026 Sale

According to the SEC Form 4 filing, Rider disposed of 400 shares of ResMed common stock on 23 October 2026 at a price of $255 per share. The transaction is classified as a sale under Table I — Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned. The filing confirms that all shares involved were held directly by the reporting person. No derivative securities transactions were recorded in Table II of the filing.

Rule 10b5-1 Trading Plan

The filing discloses that the share sale was conducted pursuant to a Rule 10b5-1 plan. According to the explanation of responses included in the filing, the plan was adopted on 28 February 2025. The filing further indicates the transaction box was checked to confirm that the sale was made pursuant to a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the United States Securities Exchange Act of 1934.

Beneficial Ownership Position Following the Transaction

Following the reported sale, Michael J. Rider's direct beneficial ownership of ResMed common stock stands at 12,318 shares, as disclosed in the Form 4 filing. The filing identifies Rider's relationship to ResMed as an officer, holding the title of Global General Counsel. ResMed Inc is identified in the filing with the ticker symbol RMD. The reporting person's address is listed as 9001 Spectrum Center Boulevard, San Diego, California 92123.